Overview
The objective of this prospective study is to capture the quality of life of patients with locally advanced or metastatic sarcoma, and investigate the effectiveness of support provided through a personalized web-based platform.
Eligibility
Inclusion Criteria:
- Age of ≥ 18 years.
- Diagnosis of locally advanced or metastatic sarcoma of any location and origin.
- Ability to understand and operate in a digital environment.
- Patients planned to start standard of care treatment within the next month, or are currently undergoing standard of care treatment of any line.
- Treatments include surgery, radiotherapy, chemotherapy, immunotherapy, targeted therapy, hormonal therapy, or any combination of the above.
Exclusion Criteria:
- Limited ability or willingness to report side-effects on an online platform.
- Performance status \>3.
- Life expectancy of \<6 months.
- Participation in an interventional clinical trial with investigational drugs or devices.
